AU7265298A - Methods and compositions for targeted dna differential display - Google Patents

Methods and compositions for targeted dna differential display

Info

Publication number
AU7265298A
AU7265298A AU72652/98A AU7265298A AU7265298A AU 7265298 A AU7265298 A AU 7265298A AU 72652/98 A AU72652/98 A AU 72652/98A AU 7265298 A AU7265298 A AU 7265298A AU 7265298 A AU7265298 A AU 7265298A
Authority
AU
Australia
Prior art keywords
compositions
methods
differential display
targeted dna
dna differential
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72652/98A
Inventor
Cassandra L Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston University
Original Assignee
Boston University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston University filed Critical Boston University
Publication of AU7265298A publication Critical patent/AU7265298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
AU72652/98A 1997-04-29 1998-04-29 Methods and compositions for targeted dna differential display Abandoned AU7265298A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4507897P 1997-04-29 1997-04-29
US60045078 1997-04-29
PCT/US1998/008616 WO1998049345A1 (en) 1997-04-29 1998-04-29 Methods and compositions for targeted dna differential display

Publications (1)

Publication Number Publication Date
AU7265298A true AU7265298A (en) 1998-11-24

Family

ID=21935877

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72652/98A Abandoned AU7265298A (en) 1997-04-29 1998-04-29 Methods and compositions for targeted dna differential display

Country Status (2)

Country Link
AU (1) AU7265298A (en)
WO (1) WO1998049345A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060121461A1 (en) * 2002-04-30 2006-06-08 Carsten Harms Methods for identifying and isolating unique nucleic acid sequences
AU2003225410A1 (en) 2003-03-21 2004-10-11 Academisch Ziekenhuis Leiden Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
US7387876B2 (en) * 2004-02-27 2008-06-17 President And Fellows Of Harvard College Amplification of trace amounts of nucleic acids
WO2007123391A1 (en) 2006-04-20 2007-11-01 Academisch Ziekenhuis Leiden Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly expressed gene.
EP1857548A1 (en) 2006-05-19 2007-11-21 Academisch Ziekenhuis Leiden Means and method for inducing exon-skipping
AU2007282224B2 (en) 2006-08-11 2013-08-29 Vico Therapeutics B.V. Methods and means for treating DNA repeat instability associated genetic disorders
WO2009008727A2 (en) 2007-07-12 2009-01-15 Prosensa Technologies B.V. Molecules for targeting compounds to various selected organs or tissues
AU2008317566B2 (en) 2007-10-26 2014-05-01 Academisch Ziekenhuis Leiden Means and methods for counteracting muscle disorders
USRE48468E1 (en) 2007-10-26 2021-03-16 Biomarin Technologies B.V. Means and methods for counteracting muscle disorders
NZ587178A (en) 2008-02-08 2011-11-25 Prosensa Holding Bv Methods and means for treating dna repeat instability associated genetic disorders
EP2119783A1 (en) 2008-05-14 2009-11-18 Prosensa Technologies B.V. Method for efficient exon (44) skipping in Duchenne Muscular Dystrophy and associated means
US20120046342A1 (en) 2009-04-24 2012-02-23 Prosensa Technologies B.V. Oligonucleotide comprising an inosine for treating dmd
BR112014018427B1 (en) 2012-01-27 2021-11-03 Biomarin Technologies B.V. RNA MODULATOR OLIGONUCLEOTIDES WITH IMPROVED FEATURES FOR THE TREATMENT OF DUCHENNE AND BECKER'S MUSCULAR DYSTROPHY

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018176A1 (en) * 1992-03-11 1993-09-16 Dana-Farber Cancer Institute METHODS TO CLONE mRNA
US5580726A (en) * 1994-04-29 1996-12-03 Geron Corporation Method and Kit for enhanced differential display
US5741645A (en) * 1993-06-29 1998-04-21 Regents Of The University Of Minnesota Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis
US5459037A (en) * 1993-11-12 1995-10-17 The Scripps Research Institute Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
US5565340A (en) * 1995-01-27 1996-10-15 Clontech Laboratories, Inc. Method for suppressing DNA fragment amplification during PCR
US6300060B1 (en) * 1995-11-09 2001-10-09 Dana-Farber Cancer Institute, Inc. Method for predicting the risk of prostate cancer morbidity and mortality

Also Published As

Publication number Publication date
WO1998049345A1 (en) 1998-11-05

Similar Documents

Publication Publication Date Title
AU1603199A (en) Methods and devices for measuring differential gene expression
AU9692198A (en) Gene delivery compositions and methods
EP0926468B8 (en) Display
AU8909998A (en) Methods and compositions for cloning nucleic acid molecules
AU7784398A (en) Photoluminescent display devices and methods for making
AU7275098A (en) Enhanced adenovirus-assisted transfection composition and method
AU6544598A (en) Compositions and methods for analysis of nucleic acids
AU4008495A (en) Tcl-1 gene and protein and related methods and compositions
AU6724598A (en) 5-oxysubstituted chinolines and their use as cholesterol ester transfer proteinsinhibitors
AU9600598A (en) Visual display
AU6959998A (en) Rna isolation reagent and methods
AU6508898A (en) Improved display
AU7265298A (en) Methods and compositions for targeted dna differential display
AU1390199A (en) Compositions and methods for inhibiting the activity of certain genes
AU5874798A (en) Vaccination methods and molecules
AU6950096A (en) Methods and compositions for nucleic acid targeting
AU7729498A (en) Methods and uses for transposon-based gene targeting
AU8898198A (en) Methods of identifying biological agent compositions
AU2710400A (en) Monocyte-derived nucleic acids and related compositions and methods
AU6094200A (en) Nor gene compositions and methods for use thereof
AU9357598A (en) Multipurpose display and support system
AUPM334794A0 (en) Enzyme based bioremediation
AU8074698A (en) (costal2) genes and their uses
AUPP617598A0 (en) Genetic sequence and uses therefor
AU8687098A (en) Methods and compositions for stripping nucleic acids

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase